Antigenic and virological properties of an H3N2 variant that will likely dominate the 2021-2022 Northern Hemisphere influenza season
Marcus J. Bolton, Jordan T. Ort, Ryan McBride, Nicholas J. Swanson, Jo Wilson, Moses Awofolaju, Allison R. Greenplate, Elizabeth M. Drapeau, View ORCID ProfileAndrew Pekosz, James C. Paulson, View ORCID ProfileScott E. Hensley
doi: https://doi.org/10.1101/2021.12.15.21267857
Marcus J. Bolton
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Jordan T. Ort
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Ryan McBride
2Department of Molecular Medicine and Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, California, USA
Nicholas J. Swanson
3Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Jo Wilson
3Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Moses Awofolaju
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Allison R. Greenplate
4Institute for Immunology and Immune Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Elizabeth M. Drapeau
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Andrew Pekosz
3Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
James C. Paulson
2Department of Molecular Medicine and Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, California, USA
Scott E. Hensley
1Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Article usage
Posted December 16, 2021.
Antigenic and virological properties of an H3N2 variant that will likely dominate the 2021-2022 Northern Hemisphere influenza season
Marcus J. Bolton, Jordan T. Ort, Ryan McBride, Nicholas J. Swanson, Jo Wilson, Moses Awofolaju, Allison R. Greenplate, Elizabeth M. Drapeau, Andrew Pekosz, James C. Paulson, Scott E. Hensley
medRxiv 2021.12.15.21267857; doi: https://doi.org/10.1101/2021.12.15.21267857
Antigenic and virological properties of an H3N2 variant that will likely dominate the 2021-2022 Northern Hemisphere influenza season
Marcus J. Bolton, Jordan T. Ort, Ryan McBride, Nicholas J. Swanson, Jo Wilson, Moses Awofolaju, Allison R. Greenplate, Elizabeth M. Drapeau, Andrew Pekosz, James C. Paulson, Scott E. Hensley
medRxiv 2021.12.15.21267857; doi: https://doi.org/10.1101/2021.12.15.21267857
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12603)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4476)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2867)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4233)
- Nursing (226)
- Nutrition (619)
- Oncology (2218)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6818)
- Radiology and Imaging (1502)
- Respiratory Medicine (907)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)